TELA Bio to Announce First Quarter 2026 Financial Results
TELA Bio, a NASDAQ-listed commercial-stage medical technology company specialized in soft-tissue reconstruction solutions, will report its first quarter 2026 financial results on May 12, 2026. Management will host a conference call and webcast to discuss the results and provide a corporate update. The company focuses on innovative technologies that…